Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

TxA2 antagonists/TxA2 synthase inhibitors from Fujisawa

July 12, 1996

Xenova reports on PAI inhibitor R&D

July 5, 1996

Role of adhesion molecules in hemostasis

July 5, 1996

Excellent antiplatelet activity seen with (R)-(-)-NSP-307

July 5, 1996

FK-633 in phase II trials

June 28, 1996

Fibrinogen antagonists in Terumo's pipeline

June 28, 1996

Neutralase covered under Japanese patent

June 28, 1996

Texas Biotechnology and Synthelabo enter new argatroban collaboration

June 28, 1996

BCH-2763: BioChem Therapeutic's novel thrombin inhibitor

June 28, 1996

Nippon Mining reports on HV1C3

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...